Celldex Therapeutics Inc. (CLDX)
NASDAQ · Healthcare
Celldex Therapeutics Inc. PS Ratio 2006–2026
Current and historical P/S ratio for Celldex Therapeutics Inc. (CLDX): market cap divided by trailing twelve-month revenue. As of March 31, 2026 it is 455.94.
From: 06/30/2011To: 03/31/2026
Stock Price
TTM Revenue
PS Ratio
Celldex Therapeutics Inc. PS Ratio — FAQ
Celldex Therapeutics Inc. (CLDX) ps ratio over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CLDX's ps ratio history?
The chart and table above show Celldex Therapeutics Inc.'s ps ratio by year and by quarter, including the growth rate.